The stock market witnessed an interesting shift on Friday as investors moved away from technology shares and showed stronger interest in defensive sectors such as consumer staples and healthcare.

The Nasdaq dropped more than 2%, putting pressure on technology stocks. Meanwhile, consumer staples and healthcare shares moved higher, suggesting that investors were becoming more cautious about riskier areas of the market.

One of the biggest highlights came from Regeneron Pharmaceuticals (REGN), which surged more than 12% after reporting stronger-than-expected third-quarter results. The performance added to the positive momentum across the healthcare sector.

Consumer staples also delivered an impressive session. State Street's Consumer Staples ETF (XLP) gained nearly 2%, reaching an intraday record of $90. Several companies in the sector also touched new 52-week highs.

Altria (MO) climbed more than 2% to $79, while Philip Morris International (PM) advanced 1.6% to $214. Keurig Dr Pepper (KDP) also gained 1.4%, reaching $36.

Healthcare stocks followed a similar trend. The Health Care ETF (XLV) rose 1.5% to $187, marking another 52-week high. Major holdings, including Eli Lilly (LLY), Johnson & Johnson (JNJ), Pfizer (PFE), and Gilead Sciences (GILD), all finished higher.

What caught my attention was the contrast between technology weakness and the strength in defensive sectors. When investors start shifting capital toward healthcare and consumer staples, it can signal changing market sentiment and a growing preference for stability.

The big question now is whether this rotation will continue or whether technology buyers will step back in.

Friday's market action is a reminder that leadership on Wall Street can change quickly, and investors should pay attention to where the money is moving.

#USMidtermElections #StrategySTRCReaches$99.95ForFirstTimeIn165Days #SwitzerlandFirstSpotBitcoinETFExpectedToTradeInNovember